- Published on
Medicine – Coagulation Disorders: The Coagulation Cascade
The coagulation cascade is a series of enzymatic reactions involving clotting factors that culminates in the formation of a stable fibrin clot.
It is traditionally divided into three pathways:
- Extrinsic pathway – initiated by tissue factor.
- Intrinsic pathway – classically initiated by contact activation.
- Final common pathway – generates thrombin and fibrin.
The intrinsic and extrinsic pathways converge at factor X activation. Factor Xa promotes thrombin generation, thrombin converts fibrinogen into fibrin, and factor XIIIa cross-links fibrin to stabilise the clot.
1. The Coagulation Cascade – Detailed Diagram
The following diagram illustrates the classical coagulation cascade, including the coagulation factors, cofactors and final fibrin cross-linking step.
Figure 1. Simplified classical coagulation cascade. Tissue factor initiation is central to physiological haemostasis; factor XII contact activation is particularly relevant to laboratory aPTT testing. The diagram illustrates the main reactions rather than every feedback and amplification step.
2. Extrinsic Pathway
The extrinsic pathway is initiated when vascular injury exposes tissue factor (factor III) to circulating blood.
Mechanism
- Tissue factor becomes exposed following vascular injury.
- Tissue factor binds factor VII/VIIa.
- The tissue factor–factor VIIa complex acts in the presence of calcium and phospholipids.
- Factor X is activated to factor Xa.
- The common pathway is initiated.
3. Intrinsic Pathway
The intrinsic pathway is classically represented by sequential activation of factors XII, XI and IX, followed by formation of the intrinsic tenase complex.
Sequence of Activation
- Factor XII is activated to factor XIIa in the classical contact pathway.
- Factor XIIa activates factor XI to XIa.
- Factor XIa activates factor IX to IXa.
- Factor IXa combines with factor VIIIa, calcium and phospholipids.
- The intrinsic tenase complex activates factor X.
4. Final Common Pathway
Both intrinsic and extrinsic pathways converge at the activation of factor X.
Sequence of Events
- Factor X is activated to factor Xa.
- Factor Xa combines with factor Va, calcium and phospholipids to form the prothrombinase complex.
- Prothrombin (factor II) is converted into thrombin (factor IIa).
- Thrombin converts fibrinogen (factor I) into fibrin.
- Thrombin activates factor XIII to XIIIa.
- Factor XIIIa cross-links fibrin, producing a stable clot.
Common Pathway Flowchart
5. Important Coagulation Factors and Associated Disorders
| Factor | Name / Function | Clinical Significance |
|---|---|---|
| I | Fibrinogen | Hypofibrinogenaemia or afibrinogenaemia |
| II | Prothrombin | Prothrombin deficiency |
| III | Tissue factor | Initiates tissue factor pathway |
| IV | Calcium | Required for several coagulation reactions |
| V | Proaccelerin | Cofactor in prothrombinase complex |
| VII | Proconvertin | Deficiency typically prolongs PT |
| VIII | Antihaemophilic factor A | Haemophilia A |
| IX | Christmas factor | Haemophilia B |
| X | Stuart–Prower factor | Common-pathway deficiency |
| XI | Plasma thromboplastin antecedent | Factor XI deficiency (haemophilia C) |
| XII | Hageman factor | Prolonged aPTT, usually without bleeding |
| XIII | Fibrin-stabilising factor | Delayed bleeding; PT and aPTT usually normal |
6. Coagulation Tests and Pathways
| Investigation | Pathway Assessed | Important Abnormalities |
|---|---|---|
| PT | Extrinsic and common | Warfarin, vitamin K deficiency, factor VII deficiency, liver disease, DIC |
| aPTT | Intrinsic and common | Haemophilia A/B, heparin, lupus anticoagulant |
| TT | Fibrinogen-to-fibrin conversion | Heparin, direct thrombin inhibitors, fibrinogen abnormalities |
| Bleeding time | Primary haemostasis (historical test) | Platelet dysfunction, thrombocytopenia, VWD |
7. Vitamin K-Dependent Coagulation Factors
Vitamin K is required for the gamma-carboxylation of several coagulation proteins, allowing them to bind calcium and function normally.
II, VII, IX, X
Proteins C and S are also vitamin K-dependent anticoagulant proteins.
Warfarin inhibits vitamin K recycling and reduces the functional activity of these proteins.
8. High-Yield Examination Summary
| Feature | Key Point |
|---|---|
| Extrinsic pathway | Tissue factor and factor VII; assessed by PT |
| Intrinsic pathway | Factors XII, XI, IX and VIII; assessed by aPTT |
| Common pathway | Factors X, V, II and I |
| Haemophilia A | Factor VIII deficiency |
| Haemophilia B | Factor IX deficiency |
| Factor XIII | Cross-links fibrin; deficiency may have normal PT and aPTT |
| Vitamin K-dependent factors | II, VII, IX and X |
| Final clot | Cross-linked fibrin |
9. Key Examination Pearls
- Factor VIII deficiency = Haemophilia A.
- Factor IX deficiency = Haemophilia B.
- Factor VII belongs to the extrinsic pathway.
- Factors VIII, IX, XI and XII belong to the intrinsic pathway in the classical cascade.
- Factors I, II, V and X belong to the common pathway.
- Factor XIII stabilises fibrin through cross-linking.
- Calcium (factor IV) is required for several coagulation reactions.
- Vitamin K-dependent factors are II, VII, IX and X.
- Factor XII deficiency may prolong aPTT without causing clinical bleeding.
- Factor XIII deficiency may cause bleeding despite normal PT and aPTT.
The intrinsic and extrinsic pathways converge at factor X activation. Factor Xa generates thrombin, thrombin converts fibrinogen into fibrin, and factor XIIIa cross-links fibrin to form a stable clot.
The classical coagulation cascade is a useful model for interpreting PT and aPTT, but physiological haemostasis is more complex and depends on tissue factor initiation, platelet surfaces, thrombin amplification and endogenous anticoagulant mechanisms. Coagulation test results must therefore be interpreted alongside the patient's bleeding history and clinical findings.
Kembara Xtra – Medicine Revision Notes